References
- Razin S, Yogev D, Naot Y. Molecular biology and pathogenicity of mycoplasmas. Microbiol Mol Biol Rev 1998; 62: 1094–156
- Hudson MM, Talbot MD. Ureaplasma urealyticum. Int J STD AIDS 1997; 8: 546–51
- Furr PM, Taylor-Robinson D, Webster AD. Mycoplasmas and ureaplasmas in patients with hypogammaglobulinaemia and their role in arthritis: microbiological observations over 20 y. Ann Rheum Dis 1994; 53: 183–7
- Cartner SC, Lindsey JR, Gibbs-Erwin J, Cassell GH, Simecka JW. Roles of innate and adaptive immunity in respiratory mycoplasmosis. Infect Immun 1998; 66: 3485–91
- Taylor G, Taylor-Robinson D. Effects of active and passive immunization on Mycoplasma pulmonis-induced pneumonia in mice. Immunology 1976; 30: 611–8
- Asmar BI, Andresen J, Brown WJ. Ureaplasma urealyticum arthritis and bacteraemia in agammaglobulinaemia. Pediatr Infect Dis J 1998; 17: 73–6
- Heilmann C, Jensen L, Jensen JS, et al. Treatment of resistant Mycoplasma infection in immunocompromized patients with a new pleuromutilin antibiotic. J Infect 2001; 43: 234–8
- Burdge DR, Reid GD, Reeve CE, Robertson JA, Stemke GW, Bowie WR. Septic arthritis due to dual infection with Mycoplasma hominis and Ureaplasma urealyticum. J Rheumatol 1988; 15: 366–8
- Boyle EM, Jr, Burdine J, Bolman RM III. Successful treatment of Mycoplasma mediastinitis after heart-lung transplantation. J Heart Lung Transplant 1993; 12: 508–12
- Haller M, Forst H, Ruckdeschel G, Denecke H, Peter K. Peritonitis due to Mycoplasma hominis and Ureaplasma urealyticum in a liver transplant recipient. Eur J Clin Microbiol Infect Dis 1991; 10: 172